The effects of propofol or sevoflurane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty

Acta Anaesthesiologica Belgica

Volumn 58, Issue 1, 2007, Pages 3-6

  Arnaoutoglou, H ^a,c   Vretzakis, G ^a   Souliotis, D ^a   Cambili, M ^a   Galaris, D ^b   Papadopoulos, G ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Antioxidant activity; Knee arthroplasty; Malondialdehyde; Propofol; Sevoflurane

Indexed keywords

ATRACURIUM; FENTANYL; MALONALDEHYDE; NITROUS OXIDE; OXYGEN RADICAL; PROPOFOL; SEVOFLURANE; THIOPENTAL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; ISCHEMIA; KNEE ARTHROPLASTY; MALE; OXIDATIVE STRESS; REPERFUSION INJURY; SEX DIFFERENCE; TOURNIQUET;

AGED; ANALYSIS OF VARIANCE; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; FREE RADICALS; HUMANS; MALE; MALONDIALDEHYDE; METHYL ETHERS; OXIDATIVE STRESS; PROPOFOL; REPERFUSION INJURY; TOURNIQUETS;

EID: 34247237284     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aarts L., Van Der Hee R., Dekker I., Langemeijer H., Bast A., The widely used anesthetic agent propofol can replace alphatocopherol as an antioxidant, FEBS LETTERS, 357, 83-5, 1995.
2. Aldemir O., Celebi H., Cevik C., Duzgun E., The effects of propofol or halothane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty, ACTA ANAESTHESIOL. SCAND., 45, 1221-5, 2001.
3. Chopineau J., Sommier M. F., Sautou V., Evaluation of free radical production in an ischaemia-reperfusion model in the rabbit using a tourniquet, J. PHARM. PHARMACOL., 46, 519-20, 1994.
4. Concannon M. J., Kester C. G., Welsh C. F., Puckett C. L., Patterns of free radical production after tourniquet ischemia, implications for the hand surgeon, PLASTIC AND RECONSTRUCTIVE SURGERY, 89, 846-52, 1992.
5. Conzen P. F., Fischer S., Detter C., Klaus P., Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery, ANESTHESIOLOGY, 99, 826-33, 2003.
6. De Hert S. G., Ten Broecke P. W., Mertens E., Van Sommeren E. W., De Blier I. G., Stockman B. A., Rodrigus I. E., Sevoflurane but not propofol preserves myocardial function in coronary surgery patients, ANESTHESIOLOGY, 97, 42-9, 2002.
7. Ebel D., Schlack W., Comfere T., Preckel B., Thamer V., Laboratory investigation. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart, BR. J. ANAESTH., 83, 903-8, 1999.
8. Friedl H. P., Smith D. J., Tiil G. O., Thomson P. D., Louis D. S., Ward P. A., Ischaemia-reperfusion in humans, appearance of xanthine oxidase activity, AM. J. PATHOL., 136, 491-5, 1990.
9. Granger D. N., Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury, AM. J. PHYSIOL., 255, H1269-75, 1988.
10. Green T. R., Bennet S. R., Nelson V. M., Specificity and properties of propofol as an antioxidant free radical scavenger, TOXICOL. APPL. PHARMACOL., 129, 163-9, 1994.
11. Halliwell B., Current status review, Free radicals, reactive oxygen species and human disease, a critical evaluation with special reference to atherosclerosis, BR. J. EXP. PATHOL., 70, 737-57, 1989.
12. Kahraman S., Demiryurek A. T., Propofol is a peroxynitrite scavenger, ANESTH. ANALG., 84, 1127-9, 1997.
13. Kahraman S., Kininc K., Dal D., Erdem K., Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury, BR. J. ANAESTH., 78, 279-81, 1997.
14. Kato R., Foex P., Myocardial protection by anesthetic agents against ischemia-reperfusion injury, an update for anesthesiologists, CAN. J. ANESTH., 779-91, 2002.
15. Ko S. H., Yu C. W., Lee S. K., Choe H., Chung M. J., et al., Propofol attenuates ischemia-reperfusion injury in the isolated rat heart, ANESTH. ANALG., 85, 719-24, 1997.
16. Kowalski C., Zahler S., Becker B. F., Flaucher A., Conzen P. F., Gerlach E., Peter K., Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system, ANESTHESIOLOGY, 86, 188-95, 1997.
17. Murphy P. G., Myers D. S., Davies M. J., Webster N. R., Jones J. G., The antioxidant potential of propofol (2,6 diisopropylphenol), BR. J. ANAESTH., 68, 613-8, 1992.
18. Musacchio E., Rizzoli V., Bianchi M., Bindoli A., Galzigna L., Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat, PHARMACOLOGY AND TOXICOLOGY, 69, 75-7, 1991.
19. Preckel B., Schlack W., Comfere T., Obal D., Barthel H., Thamer V., Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischemia in the rabbit heart in vivo, BR. J. ANAESTH., 81, 905-12, 1998.
20. Preckel B., Thamer V., Schlack W., Beneficial effects of sevoflurane and desflurane against myocardial reperfusion injury after cardioplegic arrest, CAN. J. ANESTH., 46, 1076-81, 1999.
21. Toller W. G., Kersten J. R., Pagel P. S., Hettrick D. A., Warltier D. C., Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs, ANESTHESIOLOGY, 1999, 91, 1437-46.
22. Zaugg M., Lucchinetti E., Spahn D. R., Pasch T., Schaub M. C., Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitichondrial KATP channels via multiple signaling pathways, ANESHESIOLOGY, 97, 4-14, 2002.